CMCR

Igor Grant Announced as New Chair of the Department of Psychiatry, University of California, San Diego

This message was sent on behalf of Dr. David Brenner, Vice Chancellor, UC San Diego Health Sciences and Dean of the School of Medicine, and Paul Viviano, Chief Executive Officer, UC San Diego Health System, to UC San Diego Health Sciences Faculty and Staff.

We are pleased to announce that Igor Grant, MD, FRCP(C), an internationally recognized neuropsychiatrist, has been named the new Chair of the Department of Psychiatry at UC San Diego School of Medicine. Dr. Grant has been at UC San Diego more than 40 years and has served as Executive Vice Chair in the department for the past 20. He will succeed Lewis Judd, MD, who is stepping down after 36 years in the position – the longest serving department chair in the history of the university.

Read more...
 

Could Medical Marijuana Laws Cut Painkiller Deaths?

ABC News, August 25, 2014

States that have legalized medical marijuana may be reaping an unintended benefit from easing up on restrictions: They appear to have nearly 25 percent fewer deaths from overdoses involving prescription painkillers, a new study found.

The  study, published today in the journal JAMA Internal Medicine, comes at a time when the United States finds itself in the throes of a growing painkiller abuse crisis. About 100 Americans die every day from narcotic painkiller overdose, according to statistics from the U.S. Centers for Disease Control and Prevention.

The researchers behind the new study suggest that because legalizing medical marijuana makes it more available to chronic pain patients, it provides a potentially less lethal alternative to pain control on a long-term basis.

Click here to read the article...


 

Welcome to the Center for Medicinal Cannabis Research


Welcome to the University of California's Center for Medicinal Cannabis Research (CMCR). The purpose of the Center is to coordinate rigorous scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical conditions. The funding of the CMCR is the result of SB 847 (Vasconcellos), passed by the State Legislature and signed into law by Governor Gray Davis. The legislation calls for a three year program overseeing objective, high quality medical research that will "enhance understanding of the efficacy and adverse effects of marijuana as a pharmacological agent," stressing that the project "should not be construed as encouraging or sanctioning the social or recreational use of marijuana" (SB 847).

 

news

 

Experts Discuss Science of Medical Marijuana

The San Diego Union-Tribune, June 7, 2014

With San Diego set to grant 36 new permits for medical marijuana dispensaries this year, the drug is about to become more legitimate than ever in the city.

Does that mean cannabis is good medicine?

Only solid science can prove what human ailments the green, leafy plant can truly soothe, but science has never been in the driver’s seat as far as marijuana is concerned.

Californians approved the Compassionate Use Act in 1996, giving doctors broad leeway to prescribe the drug if they determine “that a person’s health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine or any other illness for which marijuana provides relief.”

While much more is known today about the medical effectiveness of the species cannabis sativa than in 1996, scientists maintain that they can’t prove efficacy for many conditions that marijuana is routinely used to treat. It’s often difficult to distinguish what’s simply promising from what has peer-reviewed scientific legitimacy, researchers said.

Click here to read the article...


 
Banner
Banner
Banner

Copyright ©2010 CENTER FOR MEDICINAL CANNABIS RESEARCH | University of California, San Diego
cmcr@ucsd.edu | contact the webmaster | HNRP | HNRC | CNTN | CHARTER